Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
Stopped early · Phase 3
Conditions studied: Ovarian Cancer
In brief
This is a Phase 3, open-label, international, multi-center, efficacy, and safety study of avelumab in combination with and/or following platinum-based chemotherapy. Eligible patients must have previously untreated, histologically confirmed Stage III-IV epithelial ovarian (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) and be candidates for platinum-based chemotherapy. The primary purpose of the study is to demonstrate if avelumab given as single agent in the maintenance setting following frontline chemotherapy or in combination with carboplatin/paclitaxel is superior to platinum-based chemotherapy alone followed by observation in this population of newly diagnosed ovarian cancer patients.
Key facts
- Study ID
- NCT02718417
- Run by
- Pfizer
- People needed
- 998
- Starts
- 2016-05-19
- Expected to finish
- 2019-05-16
- Last updated by the study team
- 2020-07-14
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Alabama Oncology — Bessemer, Alabama, United States
- Alabama Oncology, Bruno Cancer Center — Birmingham, Alabama, United States
- Alabama Oncology — Birmingham, Alabama, United States
- Alabama Oncology — Birmingham, Alabama, United States
- Alabama Oncology — Birmingham, Alabama, United States
- Alabama Oncology — Birmingham, Alabama, United States
- Arizona Oncology Associates, PC - HAL — Phoenix, Arizona, United States
- Arizona Oncology Associates, PC - HAL — Phoenix, Arizona, United States
- Arizona Oncology Associates, PC - HAL — Scottsdale, Arizona, United States
- Arizona Oncology Associates, PC - HAL — Tempe, Arizona, United States
- Arizona Oncology Associates, PC-HOPE — Tucson, Arizona, United States
- Arizona Oncology Associates, PC-HOPE — Tucson, Arizona, United States
- Highlands Oncology Group — Fayetteville, Arkansas, United States
- Highlands Oncology Group — Rogers, Arkansas, United States
- Oso HomeCare — Irvine, California, United States
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California, United States
- Medical Center, Cedars-Sinai — Los Angeles, California, United States
- Gynecologic Oncology Associates — Newport Beach, California, United States
- Chao Family Comprehensive Cancer Center — Orange, California, United States
- Hematology-Oncology Medical Group of Orange County — Orange, California, United States
- Medical Oncology Care Associates — Orange, California, United States
- St. Joseph Hospital of Orange — Orange, California, United States
- The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange — Orange, California, United States
- UC Irvine Health — Orange, California, United States
- Alabama Oncology — Alabaster, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.